当前位置: 首页 >> 检索结果
61. What are the core recommendations for gout management in first line and specialist care? Systematic review of clinical practice guidelines.
作者: Brooke Conley.;Samantha Bunzli.;Jonathan Bullen.;Penny O'Brien.;Jennifer Persaud.;Tilini Gunatillake.;Michelle M Dowsey.;Peter F Choong.;Mandana Nikpour.;Rebecca Grainger.;Ivan Lin.
来源: BMC Rheumatol. 2023年7卷1期15页
Gout is the most common inflammatory arthritis, increasing in prevalence and burden. Of the rheumatic diseases, gout is the best-understood and potentially most manageable condition. However, it frequently remains untreated or poorly managed. The purpose of this systematic review is to identify Clinical Practice Guidelines (CPG) regarding gout management, evaluate their quality, and to provide a synthesis of consistent recommendations in the high-quality CPGs.
62. Cardiorespiratory fitness assessed with cardiopulmonary exercise testing in patients with juvenile idiopathic arthritis: a systematic review and meta-analysis.
作者: Eva Pella.;Vasiliki Sgouropoulou.;Marieta Theodorakopoulou.;Fotini Iatridi.;Afroditi Boutou.;Antonios Karpetas.;Aikaterini Papagianni.;Pantelis Sarafidis.;Theodoros Dimitroulas.
来源: Rheumatology (Oxford). 2023年62卷11期3526-3533页
JIA is the most common type of arthritis in children and adolescents, causing joint damage, chronic pain and disability. Deconditioning is also prevalent in patients with JIA due to both inactivity and the disease progression, resulting in reduced cardiorespiratory fitness (CRF). We aimed to evaluate CRF of patients with JIA compared with healthy controls.
63. How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies.
作者: Zhivana Boyadzhieva.;Nikolas Ruffer.;Ina Kötter.;Martin Krusche.
来源: Rheumatology (Oxford). 2023年62卷11期3518-3525页
To evaluate the effectiveness and safety of current treatment strategies for the vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome.
64. Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis.
作者: Francesco Campanaro.;Andrea Zaffaroni.;Elettra Cacioppo.;Antonella Cappelli.;Lorenza Bertù.;Marco Paolo Donadini.;Alessandro Squizzato.;Alberto Batticciotto.
来源: Rheumatology (Oxford). 2023年62卷10期3245-3255页
Preliminary data led licencing authorities to alert clinicians of an increased venous thrombotic risk associated to the use of Janus kinase (JAK) inhibitors (JAKi). We performed a systematic review to estimate the risk of venous and arterial thrombosis associated to JAKi for the treatment of immune-mediated inflammatory diseases (IMIDs).
65. Diagnosing and managing dysphagia in inclusion body myositis: a systematic review.
作者: Kevin Renz Ambrocio.;Kendrea L Focht Garand.;Bhaskar Roy.;Ankita M Bhutada.;Georgia A Malandraki.
来源: Rheumatology (Oxford). 2023年62卷10期3227-3244页
Dysphagia is a common debilitating clinical feature of IBM. However, the impact of dysphagia in IBM has been historically overlooked. This study aimed to identify, evaluate and summarize the evidence regarding the assessment and management of dysphagia in persons with IBM undergoing treatment.
66. The bidirectional association between chronic musculoskeletal pain and sleep-related problems: a systematic review and meta-analysis.
作者: Mayara Santos.;Flávia L Gabani.;Selma M de Andrade.;Bruno Bizzozero-Peroni.;Vicente Martínez-Vizcaíno.;Alberto D González.;Arthur Eumann Mesas.
来源: Rheumatology (Oxford). 2023年62卷9期2951-2962页
This systematic review and meta-analysis synthesizes the evidence on prospective bidirectional associations between sleep-related problems (SRP) and chronic musculoskeletal pain (CMP).
67. Vitamin D status and risk of rheumatoid arthritis: systematic review and meta-analysis.
作者: Joanna L Clasen.;Rachel Cole.;Dagfinn Aune.;Edward Sellon.;Alicia K Heath.
来源: BMC Rheumatol. 2023年7卷1期3页
Vitamin D is important for immunomodulation and may play a role in autoimmune diseases. Studies have reported a high prevalence of vitamin D deficiency in rheumatoid arthritis (RA) patients, and vitamin D status, assessed by circulating 25-hydroxyvitamin D [25(OH)D] concentration, is inversely associated with RA disease activity. However, it is unclear whether vitamin D deficiency increases the risk of later developing RA. We conducted a systematic review and meta-analysis of pre-diagnostic 25(OH)D concentrations and risk of RA.
68. Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration.
作者: Kazuki M Matsuda.;Ayumi Yoshizaki.;Ai Kuzumi.;Satoshi Toyama.;Kentaro Awaji.;Tomomi Miyake.;Shinichi Sato.
来源: Rheumatology (Oxford). 2023年62卷9期3139-3145页
SSc is an autoimmune disease characterized by excessive fibrosis in multiple organs, including the gastrointestinal (GI) tract. GI symptoms of SSc such as intestinal pseudo-obstruction (IPO) are often refractory to conventional intervention and can result in longer in-hospital stay or even increased mortality. We aimed to summarize the insights to date regarding the efficacy of IVIG against GI symptoms of SSc to unveil what we should focus on in future studies.
69. Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis.
作者: Andriko Palmowski.;Sabrina M Nielsen.;Zhivana Boyadzhieva.;Abelina Schneider.;Anne Pankow.;Linda Hartman.;José A P Da Silva.;John Kirwan.;Siegfried Wassenberg.;Christian Dejaco.;Robin Christensen.;Maarten Boers.;Frank Buttgereit.
来源: Rheumatology (Oxford). 2023年62卷8期2652-2660页
The aim of this study was to assess the safety and efficacy of long-term low-dose glucocorticoids (GCs) in RA.
70. CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum.
作者: David Turgeon.;Volodko Bakowsky.;Corisande Baldwin.;David A Cabral.;Marie Clements-Baker.;Alison Clifford.;Jan Willem Cohen Tervaert.;Natasha Dehghan.;Daniel Ennis.;Leilani Famorca.;Aurore Fifi-Mah.;Louis-Philippe Girard.;Frédéric Lefebvre.;Patrick Liang.;Jean-Paul Makhzoum.;David Massicotte-Azarniouch.;Arielle Mendel.;Nataliya Milman.;Heather N Reich.;David B Robinson.;Carolyn Ross.;Dax G Rumsey.;Medha Soowamber.;Tanveer E Towheed.;Judith Trudeau.;Marinka Twilt.;Elaine Yacyshyn.;Gozde K Yardimci.;Nader Khalidi.;Lillian Barra.;Christian Pagnoux.
来源: Rheumatology (Oxford). 2023年62卷8期2646-2651页
In 2020, the Canadian Vasculitis Research Network (CanVasc) published their updated recommendations for the management of ANCA-associated vasculitides (AAV). The current addendum provides further recommendations regarding the use of avacopan in AAV based on a review of newly available evidence.
71. Is Satoyoshi syndrome an autoimmune disease? A systematic review.
作者: Vinícius Viana Abreu Montanaro.;Julián Solís-García Del Pozo.;Thiago Falcão Hora.;Beatriz H León.;Carlos de Cabo.;Javier Solera.
来源: Rheumatology (Oxford). 2023年62卷7期2343-2351页
Satoyoshi syndrome is a rare multisystem disease of presumed autoimmune aetiology. We carried out a systematic review to evaluate the available evidence to support that autoimmune hypothesis.
72. Paraneoplastic arthritides: an up-to-date case-based systematic review.
作者: Suhel Gabriele Al Khayyat.;Edoardo Conticini.;Paolo Falsetti.;Stefano Gentileschi.;Antonio Vitale.;Salvatore Massimo Stella.;Miriana D'Alessandro.;Elena Bargagli.;Luca Cantarini.;Bruno Frediani.
来源: Reumatologia. 2022年60卷6期422-436页
Among the rheumatic diseases whose symptoms are more often associated with the possibility of cancer and other malignancies are systemic sclerosis, dermatomyositis and rheumatic polymyalgia. However, a differential diagnosis should be performed in each case of non-typical rheumatic disease and/or other neoplastic disease risk factors. The article's aim was based on a literature review of this subject and presentation own a case description and discussion about arthritis as a paraneoplastic syndrome. The conclusions of our analysis were as follows: more often paraneoplastic arthritis occurs in men, in ages higher than 50 years old, in patients who poorly respond to treatment of arthritis with polyarticular symmetrical involvement of the limbs, seronegative type of inflammatory joint disease. In this group of patients, complete remission after treatment of the primary tumor and recurrence of the symptoms in the presence of metastasis was observed.
73. Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis.
作者: Fanni A Meznerics.;Lajos V Kemény.;Emese Gunther.;Eszter Bakó.;Fanni Dembrovszky.;Bence Szabó.;Anna Ascsillán.;Elmar Lutz.;Dezsö Csupor.;Péter Hegyi.;András Bánvölgyi.;György Nagy.
来源: Rheumatology (Oxford). 2023年62卷6期2048-2059页
The multibiomarker disease activity (MBDA) score is an objective tool for monitoring disease activity in RA. Here we report a systematic review and meta-analysis of the clinical value of the MBDA score in RA.
74. A systematic review of the sex differences in risk factors for knee osteoarthritis.
作者: Ingrid A Szilagyi.;Jan H Waarsing.;Joyce B J van Meurs.;Sita M A Bierma-Zeinstra.;Dieuwke Schiphof.
来源: Rheumatology (Oxford). 2023年62卷6期2037-2047页
Previous systematic reviews focused on the evidence of common risk factors for knee OA (KOA); however, the effect and strength of association between risk factors and KOA might be different between the two sexes. The aim of the present systematic review was to determine the current evidence on sex differences in the association between risk factors and KOA and their prevalence.
75. COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance.
作者: Shaun Ye Song Tan.;Aaron Mingyang Yee.;Jackie Jia Lin Sim.;Cynthia Ciwei Lim.
来源: Rheumatology (Oxford). 2023年62卷5期1757-1772页
COVID-19 infection is associated with significant morbidity in systemic lupus erythematosus but is potentially preventable by vaccination, although the impact of the myriad vaccines among SLE patients is not established. We aimed to assess the effectiveness, efficacy, acceptance and safety of COVID-19 vaccination in SLE.
76. Assessment and diagnosis of the acute hot joint: a systematic review and meta-analysis.
作者: Mrinalini Dey.;Mariam Al-Attar.;Leticia Peruffo.;Ashley Coope.;Sizheng Steven Zhao.;Stephen Duffield.;Nicola Goodson.
来源: Rheumatology (Oxford). 2023年62卷5期1740-1756页
Prompt diagnosis of septic arthritis (SA) in acute native hot joints is essential for avoiding unnecessary antibiotics and hospital admissions. We evaluated the utility of synovial fluid (SF) and serum tests in differentiating causes of acute hot joints.
77. Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
作者: Samantha Sarabia.;Brandan Ranjith.;Sahil Koppikar.;Don Thiwanka Wijeratne.
来源: BMC Rheumatol. 2022年6卷1期71页
JAK inhibitors are a relatively new class of medications that may be useful in the treatment of moderate-to-severe psoriasis and psoriatic arthritis (PsA). The objective of this study was to determine the efficacy of several JAK inhibitors in treating psoriasis and PsA and examine safety concerns.
78. Withdrawal of MTX in rheumatoid arthritis patients on bDMARD/tsDMARD plus methotrexate at target: a systematic review and meta-analysis.
作者: Xiangpeng Wang.;Ziyi Tang.;Tianwen Huang.;Huifang Hu.;Yaxi Zhao.;Yi Liu.
来源: Rheumatology (Oxford). 2023年62卷4期1410-1416页
To evaluate the effect of MTX withdrawal on disease activity and remission rate in patients at target after treatment with biologic DMARDs (bDMARDs)/targeted synthetic DMARDs (tsDMARDs) plus MTX.
79. Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis.
作者: Philip J Mease.;Iain B McInnes.;Lai-Shan Tam.;Raji Rajalingam.;Steve Peterson.;Fareen Hassan.;Soumya D Chakravarty.;Christine Contré.;Alison Armstrong.;Wolf-Henning Boehncke.;Christopher Ritchlin.
来源: Rheumatology (Oxford). 2023年62卷4期1417-1425页
The IL-23 p19-subunit inhibitor guselkumab has been previously compared with other targeted therapies for PsA through network meta-analysis (NMA). The objective of this NMA update was to include new guselkumab COSMOS trial data, and two key comparators: the IL-23 inhibitor risankizumab and the Janus kinase (JAK) inhibitor upadacitinib.
80. Treating spondyloarthritis early: does it matter? Results from a systematic literature review.
作者: Dafne Capelusnik.;Diego Benavent.;Désirée van der Heijde.;Robert Landewé.;Denis Poddubnyy.;Astrid van Tubergen.;Louise Falzon.;Victoria Navarro-Compán.;Sofia Ramiro.
来源: Rheumatology (Oxford). 2023年62卷4期1398-1409页
To summarize evidence on the relationship between early treatment (definition based on symptom/disease duration or radiographic damage) and treatment clinical response in patients with SpA.
|